首页> 外文期刊>Current topics in nutraceutical research >Hedyotis Diffusa Willd. Extracts Inhibit the Proliferation and Migration of Ovarian Cancer Cells by Modulating the AKT/ERK Signaling Pathway
【24h】

Hedyotis Diffusa Willd. Extracts Inhibit the Proliferation and Migration of Ovarian Cancer Cells by Modulating the AKT/ERK Signaling Pathway

机译:Hedyotis Diffusa Willd。 提取物通过调节AKT / ERK信号通路来抑制卵巢癌细胞的增殖和迁移

获取原文
获取原文并翻译 | 示例
           

摘要

Hedyotis diffusa Willd. (HDW) is a traditional Chinese medicine used for the treatment of colorectal cancer. The aim of this study was to investigate the molecular mechanism of inhibitory effects of HDW on the growth of ovarian cancer cells. Treatment of ovarian cancer cells with increasing doses of HDW for 48 or 72h resulted in a significant reduction in the viability and colony formation of cancer cells. In HDW-treated cancer cells, the cell cycle was blocked at the G0/G1 phase and cell apoptosis was 4- to 5-fold higher than that of control group. HDW treatment also markedly inhibited the migration and invasion of ovarian cancer cells. Mechanistically, the phosphorylation levels of AKT and ERK were down-regulated in HDW-treated ovarian cancer cells. Therefore, HDW is likely to become a promising therapeutic agent for ovarian cancer treatment.
机译:Hedyotis Diffusa Willd。 (HDW)是一种用于治疗结直肠癌的中药。 本研究的目的是研究HDW对卵巢癌细胞生长的抑制作用的分子机制。 卵巢癌细胞的处理随着48或72h的增加,导致癌细胞的活力和菌落形成显着降低。 在HDW处理的癌细胞中,在G0 / G1相中封闭细胞周期,并且细胞凋亡比对照组高4-至5倍。 HDW治疗也显着抑制卵巢癌细胞的迁移和侵袭。 机械地,在HDW处理的卵巢癌细胞中,AKT和ERK的磷酸化水平下调。 因此,HDW可能成为卵巢癌治疗的有希望的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号